Identification of immunodominant T cell epitopes induced by natural Zika virus infection.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 26 06 2023
accepted: 07 08 2023
medline: 15 9 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: epublish

Résumé

Zika virus (ZIKV) is a flavivirus primarily transmitted by

Identifiants

pubmed: 37705976
doi: 10.3389/fimmu.2023.1247876
pmc: PMC10497216
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1247876

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201300021I
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201300018I
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201300015I
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States

Informations de copyright

Copyright © 2023 Eickhoff, Meza, Terry, Colbert, Blazevic, Gutiérrez, Stone, Brien, Pinto, El Sahly, Mulligan, Rouphael, Alcaide, Tomashek, Focht, Martin, Moise, De Groot and Hoft.

Déclaration de conflit d'intérêts

MM reported laboratory research and clinical trials contract funding with Lilly, Pfizer, and Sanofi; and personal fees for Scientific Advisory Board service from Merck, Meissa Vaccines, Inc. and Pfizer. Authors FT, AG, WM, LM, and ADG are (or were) employed by EpiVax, Inc, and author CF was employed by The Emmes Company, LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148638
Nat Microbiol. 2017 Mar 13;2:17036
pubmed: 28288094
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W513-8
pubmed: 18515843
Front Immunol. 2020 Sep 25;11:577546
pubmed: 33101303
Nat Commun. 2018 Aug 2;9(1):3042
pubmed: 30072692
PLoS Pathog. 2018 Sep 13;14(9):e1007237
pubmed: 30212537
BMC Bioinformatics. 2006 Mar 17;7:153
pubmed: 16545123
Cell Rep. 2020 Apr 28;31(4):107566
pubmed: 32348763
Ann Intern Med. 2021 May;174(5):585-594
pubmed: 33587687
Front Immunol. 2019 Apr 26;10:655
pubmed: 31105686
Viruses. 2018 Dec 29;11(1):
pubmed: 30597938
Clin Infect Dis. 2018 Jan 6;66(1):1-10
pubmed: 29020226
Vaccine. 2019 Aug 23;37(36):5371-5381
pubmed: 31331771
BMC Immunol. 2021 Jan 9;22(1):5
pubmed: 33421988
Front Immunol. 2019 Jul 17;10:1678
pubmed: 31379867
J Virol. 2021 May 24;95(12):
pubmed: 33789994
Int J Environ Res Public Health. 2020 May 27;17(11):
pubmed: 32471131
Vaccine. 1998 Nov;16(19):1880-4
pubmed: 9795396
PLoS One. 2021 Jun 2;16(6):e0252198
pubmed: 34077451
Clin Infect Dis. 2017 Oct 15;65(8):1260-1265
pubmed: 29017246
Viruses. 2022 Jan 25;14(2):
pubmed: 35215836
Vaccine. 2009 Sep 25;27(42):5740-7
pubmed: 19660593
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Clin Immunol. 2009 May;131(2):189-201
pubmed: 19269256
Clin Exp Immunol. 2008 Jun;152(3):522-31
pubmed: 18363743
N Engl J Med. 2021 Sep 16;385(12):e35
pubmed: 34525286
JCI Insight. 2019 Apr 18;4(8):
pubmed: 30996133
J Hepatol. 2015 Jan;62(1):48-55
pubmed: 25157982
Immunogenetics. 1999 Nov;50(3-4):201-12
pubmed: 10602880
Lancet. 2018 Feb 10;391(10120):563-571
pubmed: 29217375
Hum Vaccin Immunother. 2015;11(9):2241-52
pubmed: 26090577
Curr Protoc Microbiol. 2013 Nov 05;31:15D.3.1-15D.3.18
pubmed: 24510289
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Nat Immunol. 2016 Sep;17(9):1102-8
pubmed: 27339099
Vaccine. 2001 Aug 14;19(31):4385-95
pubmed: 11483263
NPJ Vaccines. 2021 May 13;6(1):71
pubmed: 33986292
Vaccine. 1995 Apr;13(6):581-91
pubmed: 7483779
J Virol. 2020 May 4;94(10):
pubmed: 32132233
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7852-7
pubmed: 27354515
Emerg Infect Dis. 2017 Apr;23(4):669-672
pubmed: 28084987
Lancet. 2017 Nov 4;390(10107):2099-2109
pubmed: 28647173
Open Forum Infect Dis. 2018 Dec 19;6(1):ofy352
pubmed: 30697574
Cells. 2019 Aug 03;8(8):
pubmed: 31382545
Lancet Infect Dis. 2020 Sep;20(9):1061-1070
pubmed: 32618279
Nat Commun. 2019 Feb 26;10(1):938
pubmed: 30808875
Vaccine. 2009 Oct 30;27(46):6471-9
pubmed: 19559119
Hum Vaccin Immunother. 2015;11(9):2312-21
pubmed: 26155959
Lancet. 2018 Feb 10;391(10120):552-562
pubmed: 29217376
Sci Rep. 2016 Jan 28;6:19953
pubmed: 26818736
Sci Rep. 2017 Apr 28;7(1):1283
pubmed: 28455520
Hum Vaccin Immunother. 2015;11(9):2322-8
pubmed: 26107442
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):858-867
pubmed: 30091967
Lancet Infect Dis. 2021 Sep;21(9):1282-1292
pubmed: 34019802
Trends Immunol. 2017 Aug;38(8):594-605
pubmed: 28579320
BMC Immunol. 2008 Jan 22;9:1
pubmed: 18211710
Front Immunol. 2021 May 28;12:635942
pubmed: 34127926
J Immunol. 1998 Apr 1;160(7):3363-73
pubmed: 9531296

Auteurs

Christopher S Eickhoff (CS)

Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.

Krystal A Meza (KA)

Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.

Frances E Terry (FE)

EpiVax, Inc., Providence, RI, United States.

Chase G Colbert (CG)

Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.

Azra Blazevic (A)

Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.

Andres H Gutiérrez (AH)

EpiVax, Inc., Providence, RI, United States.

E Taylor Stone (ET)

Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.

James D Brien (JD)

Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.

Amelia K Pinto (AK)

Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.

Hana M El Sahly (HM)

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.

Mark J Mulligan (MJ)

New York University Grossman School of Medicine, Division of Infectious Diseases and Immunology, New York, NY, United States.

Nadine Rouphael (N)

Emory University School of Medicine, Division of Infectious Diseases, Department of Internal Medicine, Atlanta, GA, United States.

Maria L Alcaide (ML)

University of Miami, Division of Infectious Diseases, Miller School of Medicine, Miami, FL, United States.

Kay M Tomashek (KM)

Division of Microbiology, Immunology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.

Chris Focht (C)

The Emmes Company, LLC., Rockville, MD, United States.

William D Martin (WD)

EpiVax, Inc., Providence, RI, United States.

Leonard Moise (L)

EpiVax, Inc., Providence, RI, United States.

Anne S De Groot (AS)

EpiVax, Inc., Providence, RI, United States.
University of Georgia Center for Vaccines and Immunology, Athens, GA, United States.

Daniel F Hoft (DF)

Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.
Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH